“…Death and heart failure events were observed in all studies, and non-fatal reinfarction, TVR, stent thrombosis, and angina events were analyzed in six, five, four, and four trials, respectively (Table 3). The detailed information about outcomes of four trials was acquired by sending e-mails to the first author (Lønborg et al, 2010a;2010b;Elżbieciak et al, 2013;Sörensson et al, 2013). Lønborg et al (2010a;2010b) published two articles on the same trial, followed up at 3 and 15 months, respectively …”